Ticagrelor

Contraindicated

Ticagrelor Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of fatal toxicity Details Ticagrelor Abrocitinib Cibinqo Explained Increased risk of bleeding Details Ticagrelor Defibrotide Injection Defitelio Increased risk of bleeding Details

Major

Ticagrelor Acetaminophen And Codeine Capital® & Codeine Explained Reduced absorption of ticagrelor Details Ticagrelor Abametapir Explained Increased exposure of CYP3A4 substrate Details Ticagrelor Sertraline Explained An increased risk of bleeding Details Ticagrelor Buprenorphine Belbuca Explained Reduced absorption of ticagrelor Details Ticagrelor Relugolix Orgovyx Explained Increased relugolix exposure Details Ticagrelor Simvastatin Flolipid Explained Increased simvastatin exposure and an increased risk of myopathy, including rhabdomyolysis Details Ticagrelor Alpelisib Piqray Increased alpelisib exposure and an increased risk of alpelisib-related adverse effects and toxicity Details Ticagrelor Apixaban Eliquis Explained Increased risk of bleeding and can cause serious, potentially fatal bleeding Details Ticagrelor Aspirin Acuprin® Increased risk of bleeding Details Ticagrelor Aspirin Rectal Aspirin Increased risk of bleeding Details Ticagrelor Atogepant Qulipta Reduced atogepant exposure Details Ticagrelor Betrixaban Bevyxxa® Increased risk of bleeding Details Ticagrelor Cariprazine Vraylar Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Ticagrelor Amlodipine Amvaz® Reduced amLODIPine exposure Details Ticagrelor Anagrelide Agrylin Increased bleeding risk Details Ticagrelor Bedaquiline Sirturo Increased bedaquiline exposure Details Ticagrelor Bromfenac Ophthalmic Bromday® An increased risk of bleeding Details Ticagrelor Butorphanol Injection Butorphic Reduced absorption of ticagrelor Details Ticagrelor Butorphanol Nasal Spray Stadol® NS Reduced absorption of ticagrelor Details Ticagrelor Caplacizumab-Yhdp Injection Cablivi An increased risk of bleeding Details Ticagrelor Clopidogrel Plavix Increased risk of bleeding Details Ticagrelor Cyclosporine Injection Atopica Increased cycloSPORINE exposure Details Ticagrelor Cyclosporine Ophthalmic Cequa Increased cycloSPORINE exposure Details Ticagrelor Dabigatran Pradaxa® Increased dabigatran exposure and an increased risk of bleeding Details Ticagrelor Dabigatran Etexilate Increased dabigatran exposure and an increased risk of bleeding Details Ticagrelor Diclofenac Ophthalmic Voltaren® Eye Drops An increased risk of bleeding Details Ticagrelor Diclofenac Topical (Actinic Keratosis) Pennsaid An increased risk of bleeding Details Ticagrelor Diclofenac Topical (Arthritis Pain) Pennsaid® An increased risk of bleeding Details Ticagrelor Diclofenac Transdermal Patch Flector An increased risk of bleeding Details Ticagrelor Digoxin Cardoxin® Increased digoxin exposure Details Ticagrelor Dipyridamole Permole® Increased risk of bleeding Details Ticagrelor Doxorubicin Adriamycin Increased DOXOrubicin exposure and an increased risk of DOXOrubicin-related adverse reactions Details Ticagrelor Edoxaban Savaysa Increased risk of bleeding Details Ticagrelor Encorafenib Braftovi Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Ticagrelor Epoprostenol Flolan Increased risk of bleeding Details Ticagrelor Etodolac Lodine An increased risk of bleeding Details Ticagrelor Fenoprofen Fenopron An increased risk of bleeding Details